Showing results (291-300 of 458) with videos related to
Sort By:
Pageof 46
BMJ (Clinical Research Ed.)|September 9, 2015
Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine TrialOrestis A Panagiotou, Brian L Befano, Paula Gonzalez, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 19, 2011
Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern CaliforniaPhilip E Castle, Ruth Shaber, Brandon J LaMere, et al.Lancet (London, England)|July 23, 2002
Viral load of human papillomavirus and risk of CIN3 or cervical cancerAttila T Lorincz, Philip E Castle, Mark E Sherman, et al.Cancer Cytopathology|October 24, 2018
Cytologic patterns of cervical adenocarcinomas with emphasis on factors associated with underdiagnosisRachel D Conrad, Angela H Liu, Nicolas Wentzensen, et al.The Journal of Infectious Diseases|June 2, 2011
A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History StudyNicolas Wentzensen, Ana Cecilia Rodriguez, Raphael Viscidi, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 25, 2003
Immune profiling of plasma and cervical secretions using recycling immunoaffinity chromatographyPhilip E Castle, Terry M Phillips, Allan Hildesheim, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2005
PCR testing of pooled longitudinally collected cervical specimens of women to increase the efficiency of studying human papillomavirus infectionPhilip E Castle, Mark Schiffman, Rolando Herrero, et al.Cancer Prevention Research (Philadelphia, Pa.)|February 14, 2018
Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21-39 YearsMichelle I Silver, Julia C Gage, Mark Schiffman, et al.International Journal of Cancer|August 28, 2007
High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident diseasePatti E Gravitt, Melinda Butsch Kovacic, Rolando Herrero, et al.International Journal of Cancer|September 21, 2010
Prevalence of genotype-specific human papillomavirus infection and cervical neoplasia in Taiwan: a community-based survey of 10,602 womenHui-Chi Chen, San-Lin You, Chang-Yao Hsieh, et al.Pageof 46